Second patient dies during clinical trial for obesity drug
Stephen FellerWASHINGTON, Dec. 2 (UPI) -- A second patient has died in a clinical trial for the drug beloranib, which is being tested for use with a rare obesity disorder called Prader-Willi syndrome.
Source: Health News - UPI.com - Category: Consumer Health News Source Type: news
More News: Clinical Trials | Eating Disorders & Weight Management | Health | Obesity | Prader-Willi Syndrome